Featured Resources

Introducing: LifeScienceXchange

Patients are counting on your R&D community for the next wave of life-saving medicines.

LifeScienceXchange is the catalyst: a platform for leaders from diverse life science disciplines to connect, learn and collaborate, so that together we bring new treatments to patients faster, sustainably and at scale.

Providing actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format.

It will help you understand trends, benchmark your work, inform strategy and ultimately get your new treatments to patients, faster.

Precision Medicine on LifeScienceXchange provides the events and channels for R&D to unlock human data for precise, patient-centric solutions.

LSX Logo - Better Patient Slogan

Learn faster and put new ideas to work

Market Insights unlock key learnings and actionable ideas from our industry-leading live events. We’ve cut and curated more than 6,000 hours of live recordings into quick-watch cuts, so you can get straight to the moments that matter.

Innovate sooner and benchmark success

Our Technology Showcases give you first sight of the breakthroughs driving our industry. We put you in touch with new developments and vendor success stories, so you can understand the tech, connect with the innovators and benchmark your work against the best

Learn and share ideas with industry leaders

Our Thought Leadership opportunities put you at the heart of the conversations accelerating life sciences R&D today. Hear interviews and presentations with key opinion leaders each month — and join the conversation by putting your questions to them live.

Get the full picture faster

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. Each week we identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture.

NGS

CareDx and Dovetail Genomics to Collaborate on NGS Workflow for Transplant HLA Matching

HLA matching is critical for successful transplants. The two companies hope combining their technologies will improve testing; and therefore, patient outcomes.
Clinical Diagnostics

WHO Publishes Preferred Product Characteristics for Alzheimer’s Blood Tests

The PPC outlines guidance for the development of blood tests for Alzheimer's, including important considerations to increase accessibility and diversity.
Diagnostic Development

Imaging Starts Using Brand New Radiotracer from Nuclidium

The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer.
Biomarker Analysis

Etcembly Partner With University of Surrey to Learn From Long Term Cancer Survivors’ T Cells

The analysis of cancer survivors’ T cell receptors may yield fresh targets for immunotherapies.
Diagnostic Development

GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease

GHR’s total investment in C2N has now broken $50 million since 2020.
Single Cell Analysis

New Research From Indivumed Tx Highlights Importance of Snap Freezing Tumour Samples in Target Discovery and Cancer Therapy Development

Tumour samples which were frozen after more than ten minutes were significantly different in molecular biology to samples which were frozen in less than 10 minutes.
Single Cell Analysis

National University of Singapore Unveil Novel Single-Cell RNA Analysis Technique

The novel technique effectively denoises scRNA-seq data by fitting a low-dimensional manifold in the high-dimensional space.
Biomarker Analysis

Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality

The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery